AIGAmerican International Group, Inc.
Cluster insurance Coverage sec_domestic CIK 5272 watchlist (owner, Apple Stocks, 2026-09-20) · First logged: 2026-09-23 · Slot names-insurance-2
Where this name stands
6 of 10 stages closedClosedCarried forwardOpen with the ownerFailedNot started
Next action
watch Item 5.02 8-Ks between now and the Q3 call. Two of the company's most senior people left in fifteen days — the Executive Chair who built the restructuring and the CEO of General Insurance, which after the Corebridge exit is effectively the whole company. The filings say no disagreement and the stock did not move (−0.9% across both announcements). A third departure at that level, or a named external hire into General Insurance, is the fact that decides whether this is an orderly succession or the start of something. The Q3 call on ~2026-11-04 is the first time anyone gets to ask.
Open with the owner
S6 product test / expert call, S7 conviction, S8 buy price and size.
Failed gates
none. S0/S4/S6/S7 are not closed/closed by carry-forward. S3 is closed with the one-transcript deviation named above.
| Stage | What it covers | State | What the run found |
|---|---|---|---|
| S0 | Universe & fit | Carried forward | carry-forward (cluster: Insurance — Stage 0 re-score, 2026-09-22 §5) — lens 3/4 under the SKILL.md §4.3 risk-carrying variant, which supersedes the ⚠️ 2/4 the AI-surplus four gave it in Insurance & reinsurance — cluster pass, 2026-09-22. Reserve honesty 1 (favourable in 4 of 5: +78, then −356 / −234 / −120 / −427 $m; paid-to-incurred 0.931-0.990, no drift; caveat that it is net of the adverse development cover); edge survives the cycle 1 (accident year combined ratio as adjusted 91.0 / 88.7 / 87.7 / 88.2 / 88.3 — below 95 in 5 of 5, and AIG publishes the measure itself); capital theirs 1 (1-in-250 all-peril PML $2,500m net, $1,975m after tax = 4.8% of equity — the strongest catastrophe disclosure of the seven); growth that does not dilute 0 (buybacks $6,652m and $5,836m in 2024-25 against $3,273m and $3,314m of operating cash flow, while premiums and reserves shrank). Liquidity: ADV $314.3m/day (21 sessions to 2026-09-22, ROIC NYSE:AIG). ⚠️ THIS PASS OVERTURNS THE INPUTS TO THE 0 — see S2. Glyph records the lens ran, not its verdict. |
| S1 | Source tagged | Closed | watchlist (owner, Apple Stocks, 2026-09-20). No Tier 0 promotion; second member of this slot. |
| S2 | Kill test | Closed | FY2025 revenue $26,775m, net income $3,096m, net earned premium $23,751m, equity $41,139m, reserves $70,666m, operating cash flow $3,314m (XBRL, 10-K 0000005272-26-000023). H1 2026: diluted EPS $3.18 (H1 2025 $3.13) on 537.8m diluted shares (588.5m), BVPS $77.39, adjusted tangible BVPS $72.18, total debt $9bn at 17.6% of adjusted capital. Five-year diluted share count 657.3m (2024) → 570.3m (2025) → 524.7m outstanding at 2026-06-30: about −34% from 2024. Survives easily; there is no solvency question here. Two inputs to the Stage 0 zero have reversed in 2026 and the scorecard says so rather than carrying the old reading: (1) General Insurance net premiums written +9% in Q2 and +15% over H1 2026 ($13,115m vs $11,406m) — the shrink is over; (2) the buyback is now inside operating cash flow — $1,153m of purchases in H1 2026 against $4,007m a year earlier, with $1,871m of operating cash flow and $504m of dividends. A re-score belongs in a cluster file, not here; this is the evidence for one. |
| S3 | Filings deep dive | Closed | (gate-minimum) — FY2025 10-K Item 1A Risk Factor Summary (three disclosed risks named below, in management's own ordering) and PwC's report; Q2 2026 10-Q MD&A (General Insurance and the three segment tables, Note 13, the cash flow statement); the 2026-03-31 DEF 14A ownership table; the 2026-09-02 and 2026-09-16 Item 5.02 8-Ks; the 2026-09-16 424B2 for the EUR 1.125bn note issue; the Q2 FY2026 call transcript; and a full efts.sec.gov red-flag sweep — zero "changes in accountants", one "non-reliance" hit that is a 10-Q exhibit, "restatement" and "material weakness" hits all clawback exhibits, award agreements or ICFR boilerplate; no NT 10-K, no 10-K/A or 10-Q/A in the index. PwC, PCAOB 238, sole CAM the loss reserves ($41.8bn net at 2025-12-31). Deviation: one transcript, not two. |
| S4 | Industry/supply map | Carried forward | carry-forward (cluster: Insurance & reinsurance — cluster pass, 2026-09-22 §2) — large-account commercial, absorbs loss, paid on risk margin, "worst-exposed segment" to soft pricing. |
| S5 | Ownership check | Closed | 13F by manager at 2026-06-30 (BlackRock 48.9m sh / $3,647m; Wellington 30.3m, +1.96m, the largest active add; State Street 25.1m; Harris Associates 20.4m, −0.24m; Hotchkis & Wiley +1.61m; Diamond Hill −2.34m; Ameriprise −6.73m), 13D/G census (no activist, no strategic block). Insider ownership ≈0.6% — 22 directors and executive officers hold 3,238,630 shares and no individual holds 1%, the thinnest alignment of any name in this cluster. Short interest 8,709,587 shares at the 2026-08-31 settlement (~1.7% of shares out, 3.2 days to cover), rising three settlements running from 7.42m. Buyback $2.6bn remaining at 2026-07-31; ~2m shares / ~$195m in July alone. Shelf: AIG files off an existing shelf (File No. 333-277075) and drew EUR 1.125bn on it on 2026-09-16. ⚠️ the Q2-26 13F quarter is incompletely ingested (764 filers vs 1,108) — both Vanguard entities, Geode, Franklin, GQG, Morgan Stanley, both Capital entities, Dimensional and Northern Trust have no filing in it, so no "exit" may be read from an absence. ⚠️⚠️ the Sixth Street row is NOT a holding — sixth issuer, see the log. |
| S6 | Scuttlebutt | Closed | carry-forward (cluster: Insurance & reinsurance — cluster pass, 2026-09-22 §4) — two claim rows from the 2026-09-07 Real Eisman Playbook: "I am recommending AIG" (Tunis) and "And full disclosure, everybody, I own AIG" (Eisman). ⚠️ BOTH PRE-DATE THE 2026-09-01 AND 2026-09-16 8-Ks and neither speaker had seen them. Product test / expert call open OPEN (user) |
| S7 | Written thesis + test | Carried forward | carry-forward (cluster: Insurance & reinsurance — cluster pass, 2026-09-22 §5) — "self-help is real and nearly complete; the residual is a price-taker in the softest segment", kill criterion "buyback pace falls below the pace of premium decline". That criterion has now half-fired in a way it did not anticipate — the buyback fell 71% while premiums turned UP. Replaced below. Conviction open OPEN (user) |
| S8 | Valuation & sizing | Open with the owner | OPEN (user) — see the model below. P/B 0.97 and P/adjusted-tangible -book 1.04 at $75.18 (2026-09-22) — the only P&C name in this cluster at or below book. Base ~$92, bear ~$60, bull ~$130. Buy price and size are owner-only. |
| S9 | Watchlist/monitoring | Closed | trigger written; next earnings ~2026-11-03/04 (DERIVED from filing cadence: Q3 results 8-Ks landed 2024-11-04 and 2025-11-04; Equibles' IR calendar was not queried for this name and ROIC.ai's needs a paid plan). Tier 0 EDGAR sweep covers the feed (cik 5272), and on this name Item 5.02 is the form to watch, not the 10-Q. |
Kill criteria
Specific and testable, from the dossier’s evidence- A third senior departure at Executive Chair / segment-CEO level before the Q3 2026 call, or a General Insurance CEO hired from outside. Two in fifteen days is a pattern; three is a verdict.
- U.S. excess casualty strengthening exceeds the workers' compensation release in any quarter. Q2 2026 was $74m adverse against $177m favourable. The favourable line is a book AIG has been running off for a decade; the adverse one is accident years 2016 and 2023, which are not finished.
- The accident-year combined ratio as adjusted crosses 90 while net premiums written still grow — i.e. the growth is being bought. It was 88.1 in Q2 2026 and has been 87.7-88.3 for three years.
- The buyback returns above operating cash flow while the euro notes are outstanding. AIG has just refinanced EUR 821m of 1.875% paper with 4.250% and 4.750% notes and taken on ~EUR 300m more; debt is 17.6% of adjusted capital. Borrowing at 4.75% to buy stock at book is a different bet from buying it with underwriting earnings.
Sources
10 documents cited by the connection mapWhat this profile was read from. Every edge on the map below cites one of these keys and a locator inside it; anything the run took from background knowledge or a search summary is marked as such in the dossier text rather than listed here.
| Key | Document | Where it came from | Retrieved |
|---|---|---|---|
| 10K-2025 | AIG 10-K for FY2025, filed 2026-02-12 | https://www.sec.gov/Archives/edgar/data/5272/000000527226000023/aig-20251231.htm | 2026-09-23 |
| 10Q-Q2-26 | AIG 10-Q for the quarter ended 2026-06-30, filed 2026-08-07 | https://www.sec.gov/Archives/edgar/data/5272/000000527226000076/aig-20260630.htm | 2026-09-23 |
| 8K-ZAFFINO | AIG 8-K filed 2026-09-02 (event 2026-09-01), Item 5.02 — Executive Chair steps down | https://www.sec.gov/Archives/edgar/data/5272/000000527226000088/aig-20260901.htm | 2026-09-23 |
| 8K-HANCOCK | AIG 8-K filed 2026-09-16, Item 5.02 — CEO of General Insurance retires | https://www.sec.gov/Archives/edgar/data/5272/000000527226000091/aig-20260916.htm | 2026-09-23 |
| 424B2-EUR | AIG 424B2 filed 2026-09-16 — EUR 1.125bn of 2031 and 2036 notes, settling 2026-09-24 | https://www.sec.gov/Archives/edgar/data/5272/000110465926108322/tm2623943-3_424b2.htm | 2026-09-23 |
| DEF14A-26 | AIG DEF 14A filed 2026-03-31 (director and officer ownership table) | https://www.sec.gov/Archives/edgar/data/5272/000000527226000039/aig-20260331.htm | 2026-09-23 |
| 13F-Q2-26 | Institutional holders by manager, 13F report date 2026-06-30 (ingestion incomplete — see the edge note) | python ledger/research/tools/threespread.py holders AIG | 2026-09-23 |
| CALL-Q2-26 | AIG Q2 FY2026 earnings call, 2026-08-07, speaker-labelled transcript | Equibles GetEarningsCallTranscript(ticker=AIG, fiscalYear=2026, fiscalQuarter=2) — https://equibles.com/stocks/aig/earnings-calls | 2026-09-23 |
| CLUSTER-INS-RESCORE | Insurance Stage 0 re-score, 2026-09-22, slot cluster-insurance-rescore (§5 is this name) | ledger/research/_clusters/cluster-insurance-rescore-2026-09-22.md | 2026-09-23 |
| CLUSTER-INS | Insurance & reinsurance cluster pass, 2026-09-22, slot cluster-insurance (S4 / S6 / S7) | ledger/research/_clusters/cluster-insurance-2026-09-22.md | 2026-09-23 |
- Dossier, 23 Sep 2026 — the evidence this run read, never edited after that day
- Insurance — Stage 0 re-score, 2026-09-22 — holds the stages carried forward to this name
- Insurance & reinsurance — cluster pass, 2026-09-22 — holds the stages carried forward to this name
- Every filing on EDGAR — CIK 5272, the feed the daily sweep watches
Connection map
19 edges · 14 nodes · 10 documentsEvery edge carries the document it was read from and where in it. Kinds in use: context (6), holds (3), key person risk (2), officer of (2), acquired (2), director of (1), auditor of (1), issuer of (1), governance structure (1).
| From | Link | To | As of | Evidence |
|---|---|---|---|---|
| Peter Zaffino (Executive Chair until 2026-09-15; Senior Advisor to the CEO thereafter) | key person risk | AIG | 2026-09-01 | 8K-ZAFFINO — Item 5.02, first and second paragraphs |
| John Rice (Lead Independent Director; Chair of the Board from 2026-09-15) | director of | AIG | 2026-09-15 | 8K-ZAFFINO — Item 5.02, first paragraph |
| Jon Hancock (EVP and CEO, General Insurance, until 2026-12-31) | key person risk | AIG | 2026-09-16 | 8K-HANCOCK — Item 5.02, sole paragraph |
| Eric Andersen (President and CEO) | officer of | AIG | 2026-09-16 | 8K-HANCOCK — Item 5.02, sole paragraph — 'Mr. Hancock will report to Eric Andersen, President & Chief Executive Officer of AIG' |
| Keith Walsh (CFO) | officer of | AIG | 2026-08-07 | CALL-Q2-26 — Q2 FY2026 call, prepared remarks, second speaker |
| PricewaterhouseCoopers LLP (PCAOB ID 238) | auditor of | AIG | 2026-02-12 | 10K-2025 — Report of Independent Registered Public Accounting Firm, Critical Audit Matters — 'Valuation of Insurance Liabilities - Unpaid Losses and Loss Adjustment Expenses (Loss Reserves), Net of Reinsurance' |
| AIG | context | AIG | 2026-06-30 | 10Q-Q2-26 — MD&A, General Insurance underwriting results table |
| AIG | context | AIG | 2026-07-31 | 10Q-Q2-26 — Condensed consolidated statement of cash flows, financing activities; Note 13, Repurchase of AIG Common Stock |
| AIG | issuer of | Euronext Dublin (Global Exchange Market) | 2026-09-16 | 424B2-EUR — Prospectus supplement cover and 'Use of Proceeds' summary, p. S-3 |
| AIG | acquired | Corebridge Financial, Inc. | 2026-05-31 | CALL-Q2-26 — Q2 FY2026 call, CFO prepared remarks, capital management paragraph |
| AIG | acquired | Everest Group (insurance operations in Colombia; US renewal rights) | 2026-08-07 | CALL-Q2-26 — Q2 FY2026 call, CEO prepared remarks, geographic presence paragraph |
| Eric Andersen (President and CEO) | context | AIG | 2026-08-07 | CALL-Q2-26 — Q2 FY2026 call, answer to Mayor Shields (KBW) on social inflation |
| AIG | context | AIG | 2026-06-30 | CALL-Q2-26 — Q2 FY2026 call, CFO prepared remarks, prior-year development paragraph |
| BlackRock, Inc. | holds | AIG | 2026-06-30 | 13F-Q2-26 — 13F-HR, accession 0002012383-26-003238 (holders table, row 1) |
| Wellington Management Group LLP | holds | AIG | 2026-06-30 | 13F-Q2-26 — 13F-HR, accession 0000902219-26-000311 (holders table, row 2) |
| Harris Associates L.P. | holds | AIG | 2026-06-30 | 13F-Q2-26 — 13F-HR, accession 0000813917-26-000042 (holders table, row 4) |
| Sixth Street Partners Management Company, L.P. | context | Charles Schwab Investment Management, Inc. | 2026-06-30 | 13F-Q2-26 — threespread.py holders AIG — identical-share-count warning, rows 14 and 15 |
| AIG | governance structure | AIG | 2026-03-31 | DEF14A-26 — Ownership of common stock table and footnote |
| AIG | context | AIG | 2026-02-12 | 10K-2025 — Item 1A, Risk Factor Summary, 'Employees and Competition', p.12 |
Every document keyed above is listed in Sources.
Log
- 2026-09-23 — first pass, slot
names-insurance-2, model-drafted unattended by the cloud research routine. S1, S2, S3 (gate-minimum), S5 and S9 closed; S0 carried forward fromInsurance — Stage 0 re-score, 2026-09-22§5 and S4/S6/S7 fromInsurance & reinsurance — cluster pass, 2026-09-22; S8 modelled and left open. Run finding: two Item 5.02 8-Ks fifteen days apart removed the Executive Chair from the Board and put the CEO of General Insurance on a retirement path, against a stock that moved −0.9% across both and scuttlebutt written between them that reflects neither. Second finding: both inputs to the Stage 0 test-4 zero reversed in H1 2026 — buybacks $1,153m (from $4,007m) inside $1,871m of operating cash flow, and General Insurance net premiums written +15%. A cluster re-score should carry that, not this file. Third: management says social inflation "hasn't" moderated and is not pricing for it, in the same week Allstate's CEO attributed large releases to tort reform — two carriers, opposite readings, one booking releases on it. Fourth: EUR 1.125bn of new notes on 2026-09-16 refinance EUR 821m of 1.875% paper due June 2027 at 4.250%/4.750%. Tooling: the Sixth Street / Charles Schwab IM 13F defect appears for the sixth issuer (4,343,856 shares); row discarded. Also recorded: the Equibles transcripts for both names in this slot mis-assign speaker labels (analyst names on management turns and vice versa) — two for two, so every attribution from that source needs an internal check before it is carried. Evidence and access limits indossier-2026-09-23.md. Nothing here is human-verified.
Dossier, 23 Sep 2026
Never edited after the day it was writtenAIG — dossier, 2026-09-23
Slot names-insurance-2, second member. Model-drafted unattended by the cloud research routine. Nothing here is human-verified. Every figure carries the document it was read from; anything from background knowledge is marked [background]. Quotes were located by exact substring search in a text extraction of the filing and copied out — never re-typed.
Stage 0 for this name is _clusters/cluster-insurance-rescore-2026-09-22.md §5 (lens 3/4). This dossier does not re-score it; it records evidence that contradicts two of its inputs.
1. Two Item 5.02 filings, fifteen days apart
| Filed | Item | Content |
|---|---|---|
| 2026-09-02 (event 2026-09-01) | 5.02 | Peter Zaffino notified the Board that "he will step down as Executive Chair and a member of the Board, effective September 15, 2026", becoming Senior Advisor to the CEO. "John Rice, the Company's Lead Independent Director, will become Chair of the Board". The filing states his "resignation is not due to any disagreement with the Company, its management or the Board", and an amendment to his November 2022 employment agreement confirms no compensation change and that the transition is neither a termination without Cause nor one for Good Reason. |
| 2026-09-16 | 5.02 | Jon Hancock, EVP and CEO, General Insurance, "will retire and transition to the role of Senior Advisor, effective December 31, 2026", after more than six years in executive leadership at AIG and a 40-year career. He will report to Eric Andersen, President & CEO. |
Why this is the run's finding rather than a governance footnote. After the Corebridge exit completed in May 2026, General Insurance is AIG. Its CEO is leaving. The Executive Chair who ran the transformation left the Board two weeks earlier. And AIG's own FY2025 10-K carries, in the Item 1A Risk Factor Summary on p.12:
"Competition for employees in our industry is intense, and managing key employee succession is critical to our success."
Hancock was on the Q2 call on 2026-08-07 — the CEO's prepared remarks introduce him as joining for Q&A as a sitting segment head. Forty days later he is retiring.
The market did not react. ALL's shares moved −9% in three sessions after its August catastrophe release; AIG closed $75.88 on 2026-09-01 and $76.07 on 2026-09-16 — the two announcement days — and $75.18 on 2026-09-22 (ROIC NYSE:AIG). Volume on 2026-09-18 was 7.7m against a 21-session average of about 4.1m, but the price did not move with it. This dossier records that as an observation, not as evidence of anything.
2. Two inputs to the Stage 0 zero have reversed
The re-score gave AIG 0 on test 4, "growth that does not dilute", on this reasoning: buybacks of $6,652m (2024) and $5,836m (2025) against operating cash flow of $3,273m and $3,314m, with net earned premium down 24% and reserves down 11% over five years — capital return funded by divestiture rather than underwriting. H1 2026 says the opposite on both legs.
Capital return is now inside cash flow. From the Q2 2026 10-Q cash flow statement:
| Six months ended 30 June ($m) | 2026 | 2025 |
|---|---|---|
| Net cash provided by operating activities | 1,871 | 1,335 |
| Purchase of common stock | (1,153) | (4,007) |
| Dividends on common stock | (504) | (488) |
| Issuance of long-term debt | — | 1,241 |
Buybacks fell 71% year on year and now sit below operating cash flow even after the dividend. $2.6bn remained authorised at 2026-07-31, and "Pursuant to a Rule 10b5-1 plan, from July 1, 2026 to July 31, 2026, we repurchased approximately 2 million shares of AIG Common Stock for an aggregate purchase price of approximately $ 195 million." — an annualised pace of roughly $2.3bn, less than half the 2025 rate.
Premiums are growing. From the Q2 2026 10-Q General Insurance table:
| ($m) | Q2 2026 | Q2 2025 | Chg | H1 2026 | H1 2025 | Chg |
|---|---|---|---|---|---|---|
| Net premiums written | 7,516 | 6,880 | +9% | 13,115 | 11,406 | +15% |
| Net premiums earned | 6,196 | 5,878 | +5% | 12,248 | 11,647 | +5% |
| Underwriting income | 686 | 626 | +10% | 1,460 | 869 | +68% |
| Accident year combined ratio, as adjusted | 88.1 | 88.4 | (0.3) | 87.3 | 88.2 | (0.9) |
| Catastrophe losses and reinstatement premiums (pts) | (3.4) | (2.9) | (3.2) | (6.0) | ||
| Prior year development, net (pts) | 2.5 | 2.0 | 2.4 | 1.6 |
The five-year shrink the cluster file used ends at 2025. A re-score belongs in a dated cluster file, not in a name pass (ledger/research/README.md: never edit a cluster file after its date), so this is recorded as evidence for one rather than acted on here. The scorecard's S0 line carries a pointer to this section.
3. What the growth is, and what it costs
From the Q2 call (2026-08-07), CEO prepared remarks and CFO review:
- Net premiums written +9%, or +11% excluding North American property. Global commercial +9%, North America commercial +9%, international commercial +10%, global personal +8%.
- Global commercial retention 88%; new business $1.9bn, +37% year on year, including the strategic transactions.
- Lexington property premium retention fell nine percentage points in the quarter, deliberately: management says it is contracting the portfolio where E&S property pricing is inadequate, and that this and the pricing environment together reduced overall North America growth by over three percentage points.
- Pricing, Q2 2026: North America commercial ex-property +5%; North America retail casualty +10% with excess casualty +14%; financial lines ex-cyber flat; international commercial renewal pricing −6%, with global energy −15%. Political violence and terrorism +9% after −8% in Q1.
- Capital returned in Q2: $904m — $641m buybacks, $263m dividends.
- Expense ratio: Q2 30.8%, trailing twelve months 30.7%, target below 30% for full-year 2027.
- Net investment income $871m in General Insurance, flat year on year; core fixed income +4% with new-money yields about 60bp above sales and maturities, annualised yield 4.72%; alternatives fell to $13m from $48m, private equity a $8m loss on a one-quarter lag.
- Corebridge is fully exited: ~25m shares sold for $710m in May 2026, completing the five-year separation.
- Debt $9bn, total debt to adjusted capital 17.6%. BVPS $77.39 (+4% y/y); adjusted tangible BVPS $72.18 (+3%).
On the buyback, the CEO's stated logic is explicitly a book-value argument:
"Given our current share price at a modest premium to tangible book value, we view the repurchase of our shares as a very attractive use of capital." — Q2 FY2026 call, CEO prepared remarks
At $75.18 against $72.18 of adjusted tangible book, that premium is about 4%.
4. The reserve composition, and a direct contradiction with ALL
Q2 2026 prior-year development, from the CFO's prepared remarks: $145m favourable net, comprising $146m of net favourable loss reserve development, $26m of ADC amortisation and $27m of prior-year return premiums. The composition:
| Line | Q2 2026 |
|---|---|
| U.S. workers' compensation | +$177m favourable |
| U.S. property and special risks | +$79m favourable |
| U.S. excess casualty | −$74m adverse, "predominantly in accident years 2016 and 2023" |
This is the same shape the ACGL pass found on 2026-09-22 — short-tail and run-off lines releasing while the long tail strengthens — in a different issuer, and it is disclosed voluntarily here rather than extracted from a table.
And then the contradiction. Asked what he is seeing on social inflation, AIG's CEO said:
"we haven't seen anything that says that it's moderating at this point. And we're certainly not building that into our pricing at this stage." — Q2 FY2026 call, answer to Mayor Shields (KBW)
Allstate's CEO, on a call the day before (2026-08-06), explained four consecutive quarters of large favourable auto development by pointing at tort reform in Florida, Georgia and Louisiana and new legislation in New York, and said he is hopeful that trend continues (see ALL/dossier-2026-09-23.md §4). Two US carriers, one day apart, reading the same litigation environment in opposite directions — and only one of them is booking reserve releases on it. Personal auto and large-account commercial are not the same exposure, so this is not a straight contradiction of fact; it is a difference in what each management is willing to capitalise, and it is worth an owner's attention because the board's own scuttlebutt row recommends one of them.
5. The euro note issue
On 2026-09-16 AIG priced €1,125,000,000 of senior unsecured notes off shelf File No. 333-277075: €625m of 4.250% Notes due 2031 and €500m of 4.750% Notes due 2036, interest accruing from 2026-09-24, with application made to list on Euronext Dublin's Global Exchange Market. Net proceeds approximately €1,114m.
"We intend to use the net proceeds from this offering for general corporate purposes, which may include the repayment of the approximately €821 million outstanding aggregate principal amount of our 1.875% Notes due June 2027" — 424B2 filed 2026-09-16, "Use of Proceeds" summary, p. S-3
Read plainly: €821m of 1.875% money is being replaced with 4.250%–4.750% money — a coupon roughly 2.4 to 2.6 times higher on the refinanced portion — and about €300m of incremental debt is being raised on top. Against $9bn of total debt at 17.6% of adjusted capital that is not a solvency event; it is a cost-of-capital fact that belongs in any 2027-28 earnings model, and it is why one of the replacement kill criteria is about borrowing to buy stock.
6. Kill test (S2) — the numbers
FY figures from XBRL company-concept series (10-K accession 0000005272-26-000023); H1 2026 from the Q2 10-Q.
| 2021 | 2022 | 2023 | 2024 | 2025 | H1 2026 | |
|---|---|---|---|---|---|---|
| Net earned premium ($m) | 31,285 | 26,765 | 25,564 | 23,537 | 23,751 | 12,248 (GI) |
| Net income ($m) | n/r | n/r | n/r | (1,404) | 3,096 | 1,742 |
| Diluted shares (m) | n/r | n/r | n/r | 657.3 | 570.3 | 537.8 |
| Operating cash flow ($m) | 6,223 | 4,134 | 6,243 | 3,273 | 3,314 | 1,871 |
| Buybacks ($m) | 2,592 | 5,200 | 2,961 | 6,652 | 5,836 | 1,153 |
| Reserves ($m) | 79,026 | 75,167 | 70,393 | 69,168 | 70,666 | n/r |
| Equity ($m) | 65,956 | 40,970 | 45,351 | 42,521 | 41,139 | 40,606 |
Equity has fallen every year since 2023 while shares outstanding fell 34% — the per-share arithmetic is the denominator, which is exactly what the re-score said. What is new is that the numerator turned up in 2026 and the denominator work slowed.
Diluted EPS H1 2026 $3.18 against $3.13 — flat, on an 8.6% smaller share count, so net income to common fell about 8%. Adjusted after-tax income per diluted share was $2.00 in Q2, +10% y/y; core operating ROE 11.1% in the quarter and 11.6% for the half. The gap between the GAAP and adjusted series is why S8 is modelled on the adjusted one and says so.
7. Ownership (S5)
3spread, 13F report date 2026-06-30 (threespread.py holders AIG; 764 filers against 1,108 — the quarter is incompletely ingested, no exit may be read from an absence; the named non-filers include both Vanguard entities, Geode, Franklin, GQG, Morgan Stanley, Capital World, Capital Research, Dimensional and Northern Trust).
| Manager | Shares | $m | QoQ |
|---|---|---|---|
| BlackRock | 48,935,933 | 3,647.2 | +2,264,892 |
| Wellington | 30,331,704 | 2,260.6 | +1,961,270 |
| State Street | 25,115,416 | 1,871.9 | +196,969 |
| Harris Associates | 20,357,272 | 1,517.2 | −239,706 |
| T. Rowe Price | 13,777,317 | 1,026.8 | −97,989 |
| Invesco | 13,725,750 | 1,023.0 | +863,345 |
| Hotchkis & Wiley | 11,841,030 | 882.5 | +1,610,435 |
| Diamond Hill | 6,232,910 | 464.5 | −2,343,751 |
| Ameriprise | 4,651,581 | 347.0 | −6,731,349 |
Who is on the other side: index money plus a deep-value active roster (Harris, Hotchkis, Diamond Hill, LSV, Aristotle) that is a natural holder of a sub-book insurer, with Wellington adding.
The Sixth Street row is not a holding. 4,343,856 shares reported as NEW, byte-identical to Charles Schwab Investment Management's position — the defect documented in ledger/research/README.md, now seen at a sixth issuer after QCOM, ACGL, KNSL, AX and ALL.
Insiders: 22 current directors and executive officers hold 3,238,630 shares in total, and "None of the directors, the named executives or the directors and executive officers together as a group owned more than one percent of our common stock" (DEF 14A 2026-03-31). On 524.7m shares outstanding that is about 0.6% — against Allstate's 1.55% in the same cluster. Zaffino's 218,463 options and RSUs exercisable within 60 days are inside that total, and he has now left the Board.
Short interest (Equibles/FINRA): 8,709,587 shares at the 2026-08-31 settlement, up from 7,423,123 at 2026-07-31, 3.2 days to cover — about 1.7% of shares outstanding. Negligible, and rising slowly. (Equibles also returns a model estimate for the 2026-09-15 settlement of ~9.24m shares; that is a prediction, not a FINRA figure, and is not used above.)
8. Filings read, and the red-flag sweep (S3)
Three biggest risks, in management's own ordering, from the FY2025 10-K Item 1A Risk Factor Summary (p.11), which is explicitly "a summary of the material risks and uncertainties":
- Market Conditions — "Deterioration of economic conditions, geopolitical tensions, changes in market conditions or weakening global capital markets have affected and may continue to materially affect our businesses, results of operations, financial condition and liquidity."
- Reserves and Exposures, first bullet — "The amount and timing of insurance liability claims are difficult to predict and such claims may exceed the related liability for unpaid losses and loss adjustment expenses."
- Reserves and Exposures, second bullet — "Reinsurance may be unavailable or too expensive relative to its benefit and may not be adequate to protect us against losses."
Auditor: PricewaterhouseCoopers LLP, PCAOB ID 238. Sole critical audit matter: valuation of loss reserves, net liability $41.8bn at 2025-12-31, with procedures including controls "designed to identify and address management bias and contrary evidence" and an independent PwC reserve estimate for a sample of product lines.
Red-flag sweep (efts.sec.gov full text, CIK 0000005272, 2023-01-01 to 2026-09-23):
| Query | Hits | What they are |
|---|---|---|
"changes in accountants" | 0 | — |
"non-reliance" | 1 | an exhibit to the Q3 2024 10-Q, not a non-reliance determination |
"material weakness" | 6 | 10-K and annual-report ICFR boilerplate |
"restatement" | 27 | clawback-policy and award-agreement exhibits |
No NT 10-K; no 10-K/A or 10-Q/A. The only amendments in the index are 13F-HR/A, 3/A, 4/A, 8-K/A and 13G/A. Clean.
9. Scuttlebutt (S6) — and a staleness warning
Carried from _clusters/cluster-insurance-2026-09-22.md §4, two claim rows from the 2026-09-07 Real Eisman Playbook: "I am recommending AIG" (Ryan Tunis) and "And full disclosure, everybody, I own AIG" (Steve Eisman, described there as long and recently added). Those quotes live in the board's claim files.
Both were recorded on 2026-09-07 — six days after Zaffino's resignation was filed and nine days before Hancock's retirement was. Neither speaker is reacting to either. This is the second time in two slots that carried-forward S6 has gone stale inside a fortnight (QCOM's did on 2026-09-22), and it is now a pattern worth an owner decision: cluster scuttlebutt has a shelf life of roughly two weeks on any name where Item 5.02 or a Reg FD 8-K can fire.
No new outside evidence was gathered for AIG this run — the S6 search budget went to ALL. The product test and the expert call stay ⏳ OPEN (user).
10. Evidence that is thin, and access limits
- One transcript, not two. Only the Q2 FY2026 call was read, and only turns 3–16 of 52 — the prepared remarks plus the first two Q&A exchanges. The rest of the Q&A, including anything said about succession, was not reached.
- No new S6 for this name. The only scuttlebutt is the carried-forward cluster row, which this dossier flags as stale. No analyst-coverage count and no price targets were gathered for AIG.
- No investor supplement and no Investor Day deck, though management sources its ROE and expense targets to the 2025 Investor Day. The Everest Colombia acquisition and the Everest renewal-rights transaction exist here only in management's spoken remarks, in no filing this run read.
- Form 4 transaction codes not itemised, so no insider buy/sell direction is asserted. In particular, nothing is claimed about whether Zaffino or Hancock have sold.
- Next-earnings date is derived, not scheduled — from the 2024-11-04 and 2025-11-04 Q3 results 8-Ks. Equibles' IR calendar was not queried for this name (budget), and ROIC.ai's needs a paid plan.
- The €821m/1.875% refinancing is stated as an intention in the prospectus ("may include"), not a completed redemption.
- Transcript speaker labels are unreliable — analyst names appear on management turns and the first questioner's name is wrong. Nothing was attributed from this source without an internal check inside the turn itself. The 8-K spelling "Andersen"/"Jon Hancock" is preferred over the transcript's "Anderson"/"John Hancock" throughout.